Name: Breast Cancer 2026
Start: 2026-12-14
End: 2026-12-16
Location: Italy

Conference Information

Welcome Message

Warm Welcome from Breast Cancer 2026 conference!

The 5th World Congress on Breast Cancer, taking place on December 14–15, 2026, in Rome, Italy, is designed as a meeting point for the ideas, technologies, and collaborations shaping the future of breast cancer care.

Theme: Decoding Breast Cancer through Science and Compassion

Breast Cancer 2026 provides an international forum for researchers, clinicians, surgeons, pathologists, radiologists, geneticists, and healthcare professionals to examine current developments in breast oncology.

The congress is designed to facilitate the exchange of scientific knowledge and clinical perspectives that contribute to improved patient outcomes.

The program will address key areas including tumor biology, molecular diagnostics, precision medicine, imaging, surgical approaches, targeted therapies, and survivorship. Through interdisciplinary discussions and evidence-based presentations, participants will explore emerging research and its relevance to clinical practice.

Hosted in Rome, this meeting offers an opportunity to engage with colleagues from around the world, share expertise, and strengthen collaborations that support continued progress in breast cancer prevention, diagnosis, treatment, and patient care.

Best Regards,
Sanem Channing
Program Director | Breast Cancer 2026

About the Conference

Conference Overview

The 5th World Congress on Breast Cancer is a global scientific platform dedicated to advancing breast cancer research, diagnosis, treatment, and prevention strategies. It brings together leading experts from academia, clinical practice, and industry to share cutting-edge developments in oncology.

Scientific Focus

The conference emphasizes modern breakthroughs in:

Breast cancer biology and molecular mechanisms
Precision medicine and targeted therapies
Artificial intelligence in cancer diagnostics
Immunotherapy and novel treatment approaches
Early detection and screening innovations

Knowledge Exchange

It provides an interactive environment for:

Presentation of high-impact research and clinical studies
Discussion of emerging technologies in oncology care
Collaboration between researchers, clinicians, and healthcare innovators

Participants

The congress welcomes:

Oncologists and pathologists
Researchers and academicians
Healthcare professionals and surgeons
Biomedical scientists and industry experts
Students and early-career researchers

Conference Objective

Advance research in breast cancer diagnosis, treatment, and prevention
Promote innovation in precision medicine and targeted therapies
Explore AI and emerging technologies in oncology
Encourage early detection and improved screening methods
Foster global collaboration among researchers, clinicians, and industry experts
Support young researchers in sharing scientific work
Improve patient outcomes through evidence-based practices

Scientific Sessions

1. Breast Cancer

Breast Cancer 2026 explores breast cancer as a complex disease arising from uncontrolled growth of cells within breast tissue. It encompasses diverse molecular subtypes, clinical behaviours, and therapeutic responses, making personalized management essential.

Advances scientific understanding and compassionate care to improve outcomes across the breast cancer continuum.

Key Highlights:
1.1 Breast Cancer Biology
1.2 Molecular Subtypes
1.3 Disease Progression
1.4 Personalized Management
1.5 Survivorship Strategies

Related conferences

Related Journals

2. Tumor Ecosystems

Breast Cancer 2026 examines tumor ecosystems and the dynamic interactions between cancer cells, immune cells, stromal components, and surrounding tissues. These interactions influence tumor growth, metastasis, and treatment response.

Reveals how the tumor environment shapes disease behaviour and patient-centered therapeutic strategies.

Key Highlights:
2.1 Tumor Microenvironment
2.2 Stromal Interactions
2.3 Cellular Communication
2.4 Metastatic Niches
2.5 Therapeutic Target Discovery

Related conferences

Related Journals

3. Immune Reprogramming

Breast Cancer 2026 highlights immune reprogramming approaches that modify immune responses to recognize and eliminate cancer more effectively. It explores mechanisms that overcome tumor-induced immune suppression.

Combines scientific innovation with compassionate treatment approaches to strengthen anti-cancer immunity.

Key Highlights:
3.1 Immune Checkpoints
3.2 T-Cell Engineering
3.3 Tumor Immune Escape
3.4 Immunotherapeutic Strategies
3.5 Immune Modulation Technologies

Related conferences

Related Journals

4. Oncology

Breast Cancer 2026 showcases oncology as a multidisciplinary field encompassing the study, diagnosis, treatment, and prevention of cancer. It integrates diverse expertise to improve patient outcomes through evidence-based care.

Promotes holistic breast cancer management by uniting scientific advances with compassionate clinical practice.

Key Highlights:
4.1 Cancer Biology
4.2 Clinical Oncology Advances
4.3 Precision Medicine
4.4 Integrated Care Models
4.5 Emerging Therapies

Related conferences

Related Journals

5. Digital Histology

Breast Cancer 2026 presents digital histology technologies that utilize advanced imaging and computational tools to analyse tissue specimens. It enhances diagnostic accuracy, accessibility, and workflow efficiency in pathology.

Accelerates breast cancer diagnosis through data-driven technologies that support patient-focused care.

Key Highlights:
5.1 Whole Slide Imaging
5.2 AI-Assisted Histology
5.3 Image Quantification
5.4 Digital Diagnostics
5.5 Computational Pathology

Related conferences

Related Journals

6. Molecular Imaging

Breast Cancer 2026 explores molecular imaging techniques that visualize biological processes at the cellular and molecular levels within living tissues. It provides critical insights into tumor detection and therapeutic monitoring.

Improves early diagnosis and treatment assessment through precise visualization of disease processes.

Key Highlights:
6.1 PET Imaging
6.2 Targeted Imaging Agents
6.3 Functional Imaging
6.4 Tumor Visualization
6.5 Response Monitoring

Related conferences

Related Journals

7. Radiation

Breast Cancer 2026 examines advances in radiation therapy, which uses high-energy particles or waves to destroy cancer cells while preserving healthy tissue. On-going innovations continue to improve treatment precision and safety.

Supports effective tumor control while prioritizing patient quality of life and treatment outcomes.

Key Highlights:
7.1 Precision Radiotherapy
7.2 Image-Guided Radiation
7.3 Dose Optimization
7.4 Radiation Toxicity Management
7.5 Advanced Treatment Planning

Related conferences

Related Journals

8. Hormone Signalling

Breast Cancer 2026 highlights hormone signalling pathways that regulate cellular activities and influence tumor growth. These mechanisms are particularly significant in hormone receptor-positive breast cancers.

Enhances personalized treatment approaches by understanding hormone-driven disease mechanisms.

Key Highlights:
8.1 Estrogen Signalling
8.2 Progesterone Pathways
8.3 Endocrine Resistance
8.4 Hormone Receptor Biology
8.5 Targeted Endocrine Therapies

Related conferences

Related Journals

9. Minimal Residual Disease

Breast Cancer 2026 addresses the importance of minimal residual disease, referring to small numbers of cancer cells that remain after treatment and may contribute to recurrence. Sensitive detection methods are essential for long-term monitoring.

Supports earlier intervention and improved patient outcomes through precise disease surveillance.

Key Highlights:
9.1 Residual Tumor Detection
9.2 Liquid Biopsy Applications
9.3 Disease Monitoring
9.4 Recurrence Prediction
9.5 Clinical Risk Assessment

Related conferences

Related Journals

10. Predictive Analytics

Breast Cancer 2026 showcases predictive analytics, which uses statistical models, artificial intelligence, and clinical data to forecast disease behaviour and treatment outcomes. It enables more informed clinical decision-making.

Transforms breast cancer data into actionable insights that support personalized and compassionate care.

Key Highlights:
10.1 Risk Prediction Models
10.2 Treatment Response Forecasting
10.3 AI-Based Analytics
10.4 Outcome Assessment
10.5 Clinical Decision Support

Related conferences

Related Journals

11. Early Detection

Breast Cancer 2026 emphasizes early detection strategies focused on identifying breast cancer at its earliest and most treatable stages. Timely diagnosis significantly improves survival and treatment success.

Empowers proactive care by combining scientific screening advances with patient-centered intervention.

Key Highlights:
11.1 Screening Technologies
11.2 Mammographic Advances
11.3 Risk-Based Detection
11.4 Community Awareness
11.5 Diagnostic Pathways

Related conferences

Related Journals

12. Treatment Adaptation

Breast Cancer 2026 explores treatment adaptation approaches that involve modifying therapeutic strategies based on disease evolution, patient response, and emerging clinical evidence. It supports more effective individualized care.

Ensures that treatment remains responsive to both scientific findings and patient needs.

Key Highlights:
12.1 Adaptive Therapy Models
12.2 Response-Guided Treatment
12.3 Personalized Care Strategies
12.4 Resistance Management
12.5 Dynamic Clinical Decision-Making

Related conferences

Related Journals

13. Cellular Plasticity

Breast Cancer 2026 examines cellular plasticity and the ability of cells to alter their identity, behaviour, and function in response to environmental signals. This phenomenon contributes to tumor progression and resistance.

Provides insights into cancer adaptability while identifying new opportunities for targeted interventions.

Key Highlights:
13.1 Cell State Transitions
13.2 Tumor Heterogeneity
13.3 Therapy Resistance
13.4 Epithelial-Mesenchymal Transition
13.5 Cellular Reprogramming

Related conferences

Related Journals

14. Translational Breast Cancer

Breast Cancer 2026 highlights translational breast cancer research that bridges laboratory discoveries and clinical applications. It accelerates the development of innovative diagnostics and therapies.

Transforms scientific discoveries into meaningful improvements in patient care and outcomes.

Key Highlights:
14.1 Bench-to-Bedside Research
14.2 Clinical Translation
14.3 Novel Therapeutics
14.4 Precision Oncology Applications
14.5 Translational Trial Design

Related conferences

Related Journals

15. Genetics

Breast Cancer 2026 showcases the role of genetics in exploring inherited and acquired genetic variations associated with breast cancer development and progression. It is fundamental to risk assessment and precision medicine.

Enhances individualized prevention and treatment strategies through genetic understanding.

Key Highlights:
15.1 Hereditary Breast Cancer
15.2 BRCA Mutations
15.3 Genetic Screening
15.4 Risk Stratification
15.5 Genomic Counselling

Related conferences

Related Journals

16. Tumor Hypoxia

Breast Cancer 2026 investigates tumor hypoxia, a condition characterized by reduced oxygen availability within tumor tissues that influences cancer progression and therapeutic resistance. It remains a major factor affecting treatment effectiveness.

Improves understanding of aggressive disease behaviour and opportunities for targeted therapies.

Key Highlights:
16.1 Hypoxic Signalling Pathways
16.2 Treatment Resistance
16.3 Tumor Adaptation Mechanisms
16.4 Hypoxia Biomarkers
16.5 Therapeutic Targeting Strategies

Related conferences

Related Journals

17. Biomarkers

Breast Cancer 2026 presents the growing significance of biomarkers as measurable biological indicators used for diagnosis, prognosis, and therapeutic monitoring. They provide critical information for precision oncology.

Supports individualized patient management through accurate and evidence-based decision-making.

Key Highlights:
17.1 Diagnostic Biomarkers
17.2 Prognostic Indicators
17.3 Predictive Markers
17.4 Therapeutic Monitoring
17.5 Biomarker Validation

Related conferences

Related Journals

18. Chemotherapy

Breast Cancer 2026 explores chemotherapy as a cornerstone treatment that uses cytotoxic drugs to eliminate cancer cells and reduce tumor burden across multiple disease stages.

Enhances treatment effectiveness while advancing strategies to improve patient experiences and outcomes.

Key Highlights:
18.1 Systemic Therapy Approaches
18.2 Combination Regimens
18.3 Drug Resistance Mechanisms
18.4 Toxicity Management
18.5 Personalized Chemotherapy

Related conferences

Related Journals

19. Mammary Tumor Axis

Breast Cancer 2026 examines the mammary tumor axis, encompassing the biological networks and signaling pathways that drive breast tumor initiation, growth, and progression. Understanding these pathways is critical for therapeutic development.

Decodes complex tumor biology to identify innovative and patient-focused treatment opportunities.

Key Highlights:
19.1 Tumor Signalling Networks
19.2 Growth Factor Pathways
19.3 Cellular Crosstalk
19.4 Disease Progression Mechanisms
19.5 Therapeutic Targets

Related conferences

Related Journals

20. Lymphatic Dissemination

Breast Cancer 2026 highlights lymphatic dissemination as a key mechanism through which cancer cells spread via lymphatic vessels to regional lymph nodes and distant sites. It is a critical step in breast cancer metastasis.

Strengthens understanding of disease spread while supporting earlier intervention and improved outcomes.

Key Highlights:
20.1 Lymphatic Biology
20.2 Metastatic Pathways
20.3 Sentinel Node Assessment
20.4 Tumor Cell Migration
20.5 Prognostic Implications

Related conferences

Related Journals

21. Tissue Renewal Dynamics

Breast Cancer 2026 explores tissue renewal dynamics and the mechanisms responsible for tissue maintenance, regeneration, and repair. Tissue renewal processes influence both normal breast biology and cancer development.

Links regenerative science with compassionate care to improve recovery and long-term health.

Key Highlights:
21.1 Stem Cell Dynamics
21.2 Tissue Regeneration
21.3 Cellular Turnover
21.4 Repair Mechanisms
21.5 Regenerative Biomarkers

Related conferences

Related Journals

22. Case Reports

Breast Cancer 2026 showcases case reports that provide detailed analyses of unique clinical presentations, diagnostic challenges, treatment responses, and rare disease manifestations. They contribute valuable real-world evidence to medical practice.

Transforms individual patient experiences into shared knowledge that advances both science and compassionate care.

Key Highlights:
22.1 Rare Clinical Presentations
22.2 Diagnostic Challenges
22.3 Treatment Outcomes
22.4 Multidisciplinary Management
22.5 Evidence-Based Learning

Related conferences

Related Journals

Market Analysis

Overview

The global breast cancer market continues to expand due to increasing disease incidence, improved screening programs, and the rapid adoption of targeted therapies and precision medicine.

The breast cancer therapeutics market is valued at approximately USD 35–38 billion and is expected to reach USD 80–90 billion by 2034, growing at a CAGR of 9.5–10.0%.

The broader breast cancer market was estimated at USD 26.23 billion in 2025 and is projected to reach USD 40.11 billion by 2035, expanding at a 4.34% CAGR. Additionally, the breast oncology industry segment analysed by MRFR is forecast to grow from USD 5.33 billion in 2025 to USD 12.88 billion by 2035, reflecting a 9.22% CAGR.

Regional Outlook

North America remains the leading market, accounting for 47.91% of the global breast cancer therapeutics market in 2025.
Europe benefits from strong healthcare infrastructure, extensive screening programs, and high adoption of innovative therapies.
Asia-Pacific is expected to witness the fastest growth due to increasing awareness, healthcare investments, and a large patient population.
The Top 7 Markets (US, EU4, UK, and Japan) are projected to grow at a 5.35% CAGR during 2025–2035.

Current Challenges

High cost of advanced targeted therapies and biologics.
Unequal access to treatment across developing regions.
Late-stage diagnosis in low-resource settings.
Drug resistance and disease recurrence.
Regulatory and reimbursement complexities.

Future Outlook

Expansion of precision oncology and biomarker-driven treatments.
Increased adoption of immunotherapy and antibody-drug conjugates.
Integration of AI in diagnosis and treatment planning.
Growing investment in clinical trials and personalized medicine.
Improved access to innovative therapies in emerging economies.

5th World Congress on
Breast Cancer

Quick Links

Theme: Decoding Breast Cancer through Science and Compassion

Conference Information

Welcome Message

About the Conference

Scientific Sessions

1. Breast Cancer

2. Tumor Ecosystems

3. Immune Reprogramming

4. Oncology

5. Digital Histology

6. Molecular Imaging

7. Radiation

8. Hormone Signalling

9. Minimal Residual Disease

10. Predictive Analytics

11. Early Detection

12. Treatment Adaptation

13. Cellular Plasticity

15. Genetics

16. Tumor Hypoxia

17. Biomarkers

18. Chemotherapy

19. Mammary Tumor Axis

20. Lymphatic Dissemination

21. Tissue Renewal Dynamics

22. Case Reports

Market Analysis

Regional Outlook

Current Challenges

Future Outlook